{"id":208524,"name":"EMD SERONO, INC.","slug":"emd-serono-inc","state":"MA","country":"United States of America","description":"Pharmaceutical manufacturing, research, and development.","totalSpending":1030000,"filings":22,"yearlySpending":[{"year":2021,"income":180000},{"year":2022,"income":200000},{"year":2023,"income":200000},{"year":2024,"income":200000},{"year":2025,"income":250000}],"issues":[{"code":"MMM","display":"Medicare/Medicaid"},{"code":"PHA","display":"Pharmacy"},{"code":"MED","display":"Medical/Disease Research/Clinical Labs"},{"code":"DEF","display":"Defense"}],"firms":["CAPITOL COUNSEL LLC"],"lobbyists":["ANN JABLON","ROBERT DIAMOND","MICHELLE MATHY","GENEVIEVE BELTRONE","LISA WHISLER","JOHN MARTIN"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Monitoring and engaging on health policy proposals coming before the House of Representatives and the Administration pertaining to the availability and pricing of prescription drugs.","Monitoring and engaging on health policy proposals coming before the House of Representatives and the Administration pertaining to the availability and pricing of prescription drugs.","Monitoring and engaging on health policy proposals coming before the House of Representatives and the Administration pertaining to the availability and pricing of prescription drugs.","Monitoring and engaging on health policy proposals coming before the House of Representatives and the Administration pertaining to the availability and pricing of prescription drugs.","Monitoring and engaging on health policy proposals coming before the House of Representatives and the Administration pertaining to the availability and pricing of prescription drugs."]}